Article
Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients.
Drug metabolism and personalized therapy - 24 May 2017
Tamashiro Erika Y, Felipe Claudia R, Genvigir Fabiana D V, Rodrigues Alice C, Campos Antony B, Hirata Rosario D C, Tedesco-Silva Helio, Medina-Pestana Jose O
Abstract excerpt
BACKGROUND: Polymorphisms in genes encoding for drug-metabolizing enzymes and drug transporters are among multiple factors that modulate the pharmacokinetic variability of tacrolimus (TAC) and sirolimus (SRL). This study aimed to evaluate the influence of single nucleotide polymorphisms (SNPs) on TAC and SRL dose-adjusted concentrations (C0/D) in stable kidney transplant recipients. METHODS: This is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
